Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infection.
Zang J, Zhu Y, Zhou Y, Gu C, Yi Y, Wang S, Xu S, Hu G, Du S, Yin Y, Wang Y, Yang Y, Zhang X, Wang H, Yin F, Zhang C, Deng Q, Xie Y, Huang Z.
Zang J, et al. Among authors: wang h, wang y, wang s.
Cell Discov. 2021 Aug 18;7(1):71. doi: 10.1038/s41421-021-00315-9.
Cell Discov. 2021.
PMID: 34408130
Free PMC article.